We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/OB/GYN & Women's Health

OB/GYN & Women's Health

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Enhancing Muscle Strength in Postmenopausal Women: Eight Weeks of Nitrate-Rich Beetroot Extract Supplementation Improves Muscle Function and Nitrate Bioavailability
Clinical Updatesmuscle strengthNitric Oxide

Enhancing Muscle Strength in Postmenopausal Women: Eight Weeks of Nitrate-Rich Beetroot Extract Supplementation Improves Muscle Function and Nitrate Bioavailability

By MedXY|Oct 5, 2025

Eight weeks of nitrate-rich beetroot extract supplementation significantly increases fasting nitrate and nitrite levels, improving knee extensor muscle strength and power in postmenopausal women.

ChatGPT-4o versus Gynecologic Oncologists in Endometrial Cancer Patient Communication: A Prospective Comparative Study
OB/GYN & Women's HealthChatGPT-4oEndometrial Cancer

ChatGPT-4o versus Gynecologic Oncologists in Endometrial Cancer Patient Communication: A Prospective Comparative Study

By MedXY|Oct 5, 2025

This study compares ChatGPT-4o and gynecologic oncologists in addressing endometrial cancer patient questions, showing superior AI accuracy, empathy, and completeness, though lengthy responses may challenge patient comprehension.

Promising Immunotherapy Combination Shows Durable Responses in Advanced Gynecological Clear Cell Cancers
Clinical UpdatesimmunotherapyIpilimumab

Promising Immunotherapy Combination Shows Durable Responses in Advanced Gynecological Clear Cell Cancers

By MedXY|Oct 4, 2025

A nonrandomized trial reveals that combined nivolumab and ipilimumab treatment achieves a 54% response rate with durable effects in advanced ovarian and endometrial clear cell cancers, addressing critical unmet therapeutic needs.

Unraveling Menopause: Symptom Prevalence and Severity Across the Transition—Insights from the Australian Women’s Midlife Years (AMY) Study
OB/GYN & Women's HealthMenopauseperimenopause

Unraveling Menopause: Symptom Prevalence and Severity Across the Transition—Insights from the Australian Women’s Midlife Years (AMY) Study

By MedXY|Oct 4, 2025

The AMY Study highlights vasomotor symptoms, particularly hot flushes, as key indicators of perimenopause onset, challenging traditional cycle-based definitions and underscoring the need for tailored symptom management across diverse reprod

Association of Hysterectomy With Hypertension Incidence in Korean Women: Insights from a Nationwide Cohort Study
Cardiologycohort studyHypertension

Association of Hysterectomy With Hypertension Incidence in Korean Women: Insights from a Nationwide Cohort Study

By MedXY|Oct 4, 2025

This nationwide Korean cohort study found that hysterectomy is associated with a modestly increased risk of developing hypertension in women aged 40 to 59 years, particularly in those with elevated post-surgical hemoglobin levels and after

Revealing Metabolic Subtypes in Gestational Diabetes Using Dynamic OGTT-Derived C-Peptide Trajectories: Implications for Personalized Risk and Management
Clinical UpdatesBeta-cell functionC-peptide

Revealing Metabolic Subtypes in Gestational Diabetes Using Dynamic OGTT-Derived C-Peptide Trajectories: Implications for Personalized Risk and Management

By MedXY|Oct 4, 2025

Dynamic C-peptide patterns during OGTT uncover metabolic heterogeneity in GDM, identifying insulin-resistant women at risk for fetal overgrowth and normoglycemic women at risk for preeclampsia, suggesting improved stratified treatment beyon

Elinzanetant for Vasomotor Symptoms in Endocrine Therapy for Breast Cancer: A Phase 3 Evidence Synthesis
OB/GYN & Women's Healthbreast cancerElinzanetant

Elinzanetant for Vasomotor Symptoms in Endocrine Therapy for Breast Cancer: A Phase 3 Evidence Synthesis

By MedXY|Oct 4, 2025

This review analyzes the pivotal phase 3 trial demonstrating elinzanetant’s efficacy and safety in reducing vasomotor symptoms among women undergoing endocrine therapy for HR-positive breast cancer or prevention.

Telephone-Based Weight Loss Intervention Enhances Outcomes in Women With Stage II/III Breast Cancer: Insights From the BWEL Trial and Complementary Studies
newsbreast cancerclinical trial

Telephone-Based Weight Loss Intervention Enhances Outcomes in Women With Stage II/III Breast Cancer: Insights From the BWEL Trial and Complementary Studies

By MedXY|Oct 4, 2025

A phase 3 trial demonstrates that a telephone-based lifestyle intervention achieves clinically significant weight loss in women with stage II/III breast cancer and overweight/obesity, with notable effectiveness across demographics, especial

Evaluating Digital Therapeutics for Midlife Women’s Menopausal Symptoms: A Synthesis of Recent Randomized Controlled Trials
AIdigital therapeuticsMenopause

Evaluating Digital Therapeutics for Midlife Women’s Menopausal Symptoms: A Synthesis of Recent Randomized Controlled Trials

By MedXY|Oct 4, 2025

This review synthesizes evidence on mobile digital therapeutics targeting vasomotor and behavioral health symptoms in menopausal and midlife women, highlighting efficacy, engagement, and implications for scalable symptom management.

Weight Reduction Before Conception: Enhancing Fertility and Reducing Pregnancy Complications in Overweight and Obese Women
newsfertilityGestational Diabetes

Weight Reduction Before Conception: Enhancing Fertility and Reducing Pregnancy Complications in Overweight and Obese Women

By MedXY|Oct 4, 2025

A 10%-25% preconception weight loss in overweight or obese women modestly increases pregnancy likelihood and significantly lowers gestational diabetes and hypertensive complication risks, improving maternal and neonatal outcomes.

Prenatal Exposure to Chlorpyrifos and Its Long-Term Impact on Brain Development and Motor Function in Children: Evidence from Imaging and Cohort Studies
Clinical Updatesprenatal exposure

Prenatal Exposure to Chlorpyrifos and Its Long-Term Impact on Brain Development and Motor Function in Children: Evidence from Imaging and Cohort Studies

By MedXY|Oct 4, 2025

Elevated prenatal chlorpyrifos exposure is linked to widespread brain structural abnormalities, reduced neuronal density, and impaired motor functions in children, underscoring the need for exposure minimization during pregnancy.

Drivers of Human Papillomavirus Vaccine Uptake in Migrant Populations and Interventions to Improve Coverage
newsHPV vaccinemigrant health

Drivers of Human Papillomavirus Vaccine Uptake in Migrant Populations and Interventions to Improve Coverage

By MedXY|Oct 4, 2025

This systematic review reveals multifaceted barriers to HPV vaccine uptake among migrants globally, with overall low coverage. It highlights individual, social, and systemic factors influencing uptake and delineates effective culturally tai

Extending Endocrine Treatment Duration for Early Breast Cancer
newsaromatase inhibitorsbreast cancer

Extending Endocrine Treatment Duration for Early Breast Cancer

By MedXY|Oct 4, 2025

This article reviews a patient-level meta-analysis on prolonging endocrine therapy for early breast cancer in postmenopausal women, focusing on the benefits of additional aromatase inhibitor treatment after five years of initial therapy.

Advancing Breast Cancer Detection: AI Identifies Missed Interval Cancers on Mammograms
AIartificial intelligencebreast cancer

Advancing Breast Cancer Detection: AI Identifies Missed Interval Cancers on Mammograms

By MedXY|Oct 3, 2025

A recent study shows that an AI system can detect interval breast cancers missed by radiologists on mammograms, potentially improving early diagnosis and screening outcomes in women with dense breasts.

Pregnancies Following Peri-Partum Cardiomyopathy: Insights from the ESC EuroObservational Research Programme
Cardiologyheart failurematernal outcomes

Pregnancies Following Peri-Partum Cardiomyopathy: Insights from the ESC EuroObservational Research Programme

By MedXY|Oct 3, 2025

This study analyses maternal and neonatal outcomes in subsequent pregnancies after peri-partum cardiomyopathy (PPCM), revealing lower than expected maternal risks and suggesting potential reclassification of pregnancy risk categories based

Understanding Vaginal Discharge: What’s Normal and When to Seek Help
OB/GYN & Women's Healthvaginal dischargewomen's health

Understanding Vaginal Discharge: What’s Normal and When to Seek Help

By MedXY|Oct 3, 2025

Explore the different colors and textures of vaginal discharge to understand what is normal and when changes may indicate a health issue requiring medical attention.

Understanding Female Sexual Arousal Disorder: Causes, Misconceptions, and Path to Wellness
newssexual healthwomen's health

Understanding Female Sexual Arousal Disorder: Causes, Misconceptions, and Path to Wellness

By MedXY|Oct 3, 2025

This article explores why women may experience low sexual desire, examining psychological, physiological, and lifestyle factors, while offering practical insights to improve sexual health and wellbeing.

The Microcirculation in Pregnancy: Guardian of Health or Victim of Preeclampsia?
Clinical Updatesgestational hypertensionmicrocirculation

The Microcirculation in Pregnancy: Guardian of Health or Victim of Preeclampsia?

By MedXY|Oct 2, 2025

This article explores how microcirculation functions as a key regulator in normal pregnancy but is compromised in preeclampsia, revealing early hemodynamic mechanisms behind gestational hypertension.

Revisiting Women’s Health: Pregnancy Complications and Long-Term Stroke Risk
NeurologyHypertensionischemic stroke

Revisiting Women’s Health: Pregnancy Complications and Long-Term Stroke Risk

By MedXY|Oct 2, 2025

This article explores the associations between pregnancy complications and the risk of ischemic stroke in young women, highlighting the importance of early identification for preventive measures.

Long-Term Safety of Antenatal Corticosteroids: Insights from the 50-Year Follow-Up of the Auckland Steroid Trial
newsLong-Term Safety

Long-Term Safety of Antenatal Corticosteroids: Insights from the 50-Year Follow-Up of the Auckland Steroid Trial

By MedXY|Oct 2, 2025

The 50-year follow-up study on the Auckland Steroid Trial provides reassurance about the intergenerational safety of antenatal corticosteroid exposure concerning body mass index and various health outcomes in the second generation.

Prev
19 / 24
1…1718192021…24
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles